[The effect of centrophenoxine on regional cerebral blood flow in man (author's transl)].
D000085:Acetates / Q000494:pharmacology*; D000328:Adult; D000368:Aged; D001037:Aphasia / Q000188:drug therapy; D001072:Apraxias / Q000188:drug therapy; D001794:Blood Pressure / Q000187:drug effects; D001921:Brain / Q000187:drug effects; D002343:Carotid Artery, Internal; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D005260:Female; D006429:Hemiplegia / Q000188:drug therapy; D006801:Humans; D007275:Injections, Intravenous; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy; D007553:Isotope Labeling; D008297:Male; D002504:Meclofenoxate / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D008875:Middle Aged; D013997:Time Factors; D014978:Xenon
D000085:Acetates; D014978:Xenon; D002504:Meclofenoxate
Die Wirkung von Cetrophenoxin auf die regionale Gehirndurchblutung bei Patienten mit zerebrovaskulärer Insuffizienz